Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
26
YCBD Quote, Financials, Valuation and Earnings
Last price:
$0.92
Seasonality move
:
-21.36%
Day range:
$0.91 - $1.02
52-week range:
$0.47 - $5.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.24x
P/B ratio:
1.14x
Volume:
857.4K
Avg. volume:
21.8M
1-year change:
-79.42%
Market cap:
$8.2M
Revenue:
$19.2M
EPS (TTM):
-$3.92
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, cbdMD, Inc. has 116.66% upside to fair value with a price target of $2.00 per share.
YCBD vs. S&P 500
-
Over the past 5 trading days, cbdMD, Inc. has underperformed the S&P 500 by -13.4% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
cbdMD, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
cbdMD, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter cbdMD, Inc. reported revenues of $4.7M.
Earnings Growth
-
cbdMD, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter cbdMD, Inc. reported earnings per share of -$0.08.
Enterprise value:
6.7M
EV / Invested capital:
--
Price / LTM sales:
0.24x
EV / EBIT:
60.60x
EV / Revenue:
0.35x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.12x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
3.23x
Gross Profit (TTM):
$10.8M
Return On Assets:
-19.12%
Net Income Margin (TTM):
-10.64%
Return On Equity:
-57.5%
Return On Invested Capital:
-43.37%
Operating Margin:
-14.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $24.2M | $19.5M | $19.2M | $4.6M | $4.7M | |
| Gross Profit | $13M | $11.1M | $10.8M | $2.4M | $2.5M | |
| Operating Income | -$9.3M | -$3.1M | -$2.2M | -$249K | -$685.8K | |
| EBITDA | -$6.3M | -$1.3M | -$366.7K | -$173K | -$253.3K | |
| Diluted EPS | -$12.30 | -$4.53 | -$3.92 | -$2.35 | -$0.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $36.5M | $16M | $8.1M | $6.4M | $6.6M | |
| Total Assets | $124.9M | $40.8M | $16.2M | $10.6M | $10.4M | |
| Current Liabilities | $6.9M | $5.3M | $4.7M | $8.6M | $3.2M | |
| Total Liabilities | $21.7M | $9.4M | $7.2M | $8.6M | $3.2M | |
| Total Equity | $103.1M | $31.4M | $9M | $2M | $7.2M | |
| Total Debt | $4.9M | $3.7M | $2.4M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.4M | -$428.8K | -$1.5M | $97.9K | -$240.7K | |
| Cash From Investing | $702.5K | -$290K | -$184.2K | -$110K | -$2.8K | |
| Cash From Financing | -$1.3M | $1.3M | $1.4M | -- | $1.4M | |
| Free Cash Flow | -$4.7M | -$718.8K | -$1.6M | -$12.1K | -$243.5K | |
YCBD
Sector
Market Cap
$8.2M
$26.2M
Price % of 52-Week High
15.48%
51.54%
Dividend Yield
0%
0%
Shareholder Yield
-7.23%
-1.64%
1-Year Price Total Return
-79.42%
-16.92%
Beta (5-Year)
2.083
0.489
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.06
200-day SMA
Sell
Level
$1.04
Bollinger Bands (100)
Sell
Level
0.61 - 1.29
Chaikin Money Flow
Sell
Level
-63.1M
20-day SMA
Sell
Level
$1.28
Relative Strength Index (RSI14)
Sell
Level
42.40
ADX Line
Buy
Level
26.2
Williams %R
Buy
Level
-98.1946
50-day SMA
Sell
Level
$0.97
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
577.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-20.5396)
Sell
CA Score
(Annual)
Level (-0.9617)
Buy
Beneish M-Score
(Annual)
Level (-3.6087)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.9446)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
Stock Forecast FAQ
In the current month, YCBD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YCBD average analyst price target in the past 3 months is $2.00.
-
Where Will cbdMD, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that cbdMD, Inc. share price will rise to $2.00 per share over the next 12 months.
-
What Do Analysts Say About cbdMD, Inc.?
Analysts are divided on their view about cbdMD, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that cbdMD, Inc. is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is cbdMD, Inc.'s Price Target?
The price target for cbdMD, Inc. over the next 1-year time period is forecast to be $2.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is YCBD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for cbdMD, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of YCBD?
You can purchase shares of cbdMD, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase cbdMD, Inc. shares.
-
What Is The cbdMD, Inc. Share Price Today?
cbdMD, Inc. was last trading at $0.92 per share. This represents the most recent stock quote for cbdMD, Inc.. Yesterday, cbdMD, Inc. closed at $0.92 per share.
-
How To Buy cbdMD, Inc. Stock Online?
In order to purchase cbdMD, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get YCBD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
YCBD
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
1.14x
1.81x
Price / LTM sales
0.24x
1.59x
Growth Metrics
YCBD
Sector
Revenue growth
3.61%
4.35%
Earnings growth
96.75%
9.8%
Revenue (5-year growth)
-14.45%
6.41%
Earnings forecast
--
-$0.18
Profitability
YCBD
Sector
Profitability FY 2025
$10.8M
$3.2M
Return on invested capital
-43.37%
-32.76%
Return on assets
-19.12%
-29.32%
Return on equity
-57.5%
-38.6%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Jan
17
Estimated Next Earnings Date
Apr
18
Balance Sheet
YCBD
Sector
Total cash
$2.3M
$25.4M
Short term investments
--
$25.1M
Total assets
$10.4M
$74.7M
Long term debt
--
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
